United Therapeutics Corporation
United Therapeutics Corporation scores highest on Torque (89) and lowest on Price (51). Its PosiPenta is 70.92 out of 100, better than most similar companies.
On the Penta Grid this week, United Therapeutics Corporation is Grid #14 of 837 in the Healthcare sector in United States, and Grid #36 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| United Therapeutics Corporation | 70.92 | 51 | 67 | 84 | 89 | 64 |
| Incyte Corporation | 68.96 | 55 | 61 | 83 | 86 | 60 |
| Labcorp Holdings Inc. | 67.43 | 46 | 80 | 91 | 54 | 66 |
| Quest Diagnostics Incorporated | 66.38 | 46 | 68 | 93 | 54 | 71 |
| West Pharmaceutical Services, Inc. | 63.15 | 17 | 68 | 99 | 69 | 63 |
| STERIS plc | 64.03 | 45 | 76 | 74 | 61 | 64 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 19.12 |
| P/B ratio | 3.57 |
EEarnings
| Trailing EPS | ₹2641.60 |
| Forward EPS | ₹3200.52 |
NNitro
| Price | 50494.44 |
| 52-week high | 57714.56 |
| 52-week low | 38745.05 |
| Fall from 52-week high | 12.5% |
TTorque
| Return on equity (ROE) | 19.32% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.49 |
| Market cap | ₹2,16,574 Cr |
| Insider holding | 2.00% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is United Therapeutics Corporation's PosiPenta score?
United Therapeutics Corporation's PosiPenta is 70.92 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does United Therapeutics Corporation stand on the Penta Grid?
On the Penta Grid this week, United Therapeutics Corporation is Grid #14 of 837 in the Healthcare sector in United States, and Grid #36 of 4,000 in United States.
Which PosiPenta pillar is strongest for United Therapeutics Corporation?
Torque (durability), with a score of 89 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for United Therapeutics Corporation?
Price (valuation), with a score of 51 out of 100: around the middle of similar companies.
Has United Therapeutics Corporation's PosiPenta changed since last week?
Yes, it rose 6.80 points, from 64.12 to 70.92.
PositoAI is for research and education only and is not investment advice.